| Financial Year |
March 31 2023 |
| Monetary Funds |
759,582,157.09 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
17,720,763.49 |
| Accounts Receivable |
2,349,795,248.93 |
| Advances to Suppliers |
52,461,582.69 |
| Other Receivables |
66,158,695.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
762,060,986.39 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
66,556,059.76 |
| Total Current Assets |
4,314,203,809.03 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,841,265.80 |
| Investment Properties |
12,863,318.22 |
| Fixed Assetes |
436,162,150.52 |
| Under-construction Projects |
1,757,522.12 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
153,784,873.51 |
| R&D expenses |
9,943,998.57 |
| Goodwill |
23,207,705.58 |
| Long-Term Deferred and Prepaid Expenses |
17,550,125.60 |
| Deferred Income Tax Assets |
120,763,811.64 |
| Other Non-Current Assets |
22,934,639.94 |
| Sub-Total of Non-Current Assets |
1,324,637,661.34 |
| Total Assets |
5,638,841,470.37 |
| Short-Term Loans |
1,972,664,090.24 |
| Trading Financial liabilities |
-- |
| Notes Payable |
882,960,010.00 |
| Accounts Payable |
742,888,679.34 |
| Accounts Received In Advance |
427,582.76 |
| Employee Compensation Payable |
18,617,048.47 |
| Taxes Payable |
20,813,537.02 |
| Interest Payable |
-- |
| Dividend Payable |
5,012,720.00 |
| Other payables |
133,179,331.89 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,936,558.63 |
| Other Current Liabilities |
29,175,064.80 |
| Sub-Total of Current Liabilities |
3,940,549,558.95 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
272,790,536.65 |
| Deferred Income Tax Liabilities |
11,824,876.60 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
329,309,524.29 |
| Total Liabilities |
4,269,859,083.24 |
| Paid-In Capital(Or Share Stock) |
1,268,000,000.00 |
| Capital Surplus |
2,561.81 |
| Surplus Reserve |
-- |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
28,317,439.06 |
| Minority Stockholder's Interest |
32,913,025.48 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,336,069,361.65 |
| Owner's Equity（Stockholder's Equity） |
1,368,982,387.13 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,638,841,470.37 |
